Marquette Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Marquette Asset Management's LMAT Position: Q2 2026 in Review
Marquette Asset Management sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 5 shares — an estimated $546 sold.
Marquette Asset Management first reported a position in LMAT in Q1 2026 and held it in 1 quarter. The position peaked at $546 in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Marquette Asset Management reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
- Marquette Asset Management sold 5 LeMaitre Vascular shares in Q2 2026, an estimated $546.
- Marquette Asset Management first reported a position in LeMaitre Vascular in Q1 2026 and held it in 1 quarter.
- Marquette Asset Management's LeMaitre Vascular position peaked at $546 in Q1 2026.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.